ADPT Earnings

Quarterly EPS
$-0.22
Q3 2024
$-0.23
Q4 2024
$-0.20
Q1 2025
$-0.17
Q2 2025
$0.06
Q3 2025
$-0.09
Q4 2025
$-0.13
Q1 2026
$-0.25
Q2 2026
Latest Revenue71.6M
Latest Net Income-39941000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2571.6M-39941000+21.5%-47.1%
Q1 2026-$0.1370.9M-20015000+35.1%+35.0%
Q4 2025-$0.0971.7M-13579000+51.0%+60.9%
Q3 2025$0.0694.0M9.5M+102.4%+127.3%
Q2 2025-$0.1758.9M-25593000+36.3%+45.2%
Q1 2025-$0.2052.4M-29830000+25.2%+39.4%
Q4 2024-$0.2347.5M-33717000+3.7%+52.1%
Q3 2024-$0.2246.4M-32097000+22.5%+37.1%
Q2 2024-$0.3143.2M-46248000
Q1 2024-$0.3341.9M-47533000
Q4 2023-$0.4845.8M-69467000
Q3 2023-$0.3537.9M-50326000
Adaptive Biotechnologies (ADPT) — Earnings